Hostname: page-component-5db58dd55d-pjp64 Total loading time: 0 Render date: 2026-07-07T01:50:37.786Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on Lannon et al. “Mixed Methods Survey to Identify Barriers to Accessing Deep Brain Stimulation for Movement Disorders in Canada”

Published online by Cambridge University Press:  03 October 2025

Camila Aquino Open the ORCID record for Camila Aquino [Opens in a new window]
Camila Aquino*
Affiliation:
Department of Clinical Neurosciences and Department of Community Health Sciences, University of Calgary, Hotchkiss Brain Institute, Calgary, AB, Canada
*
Corresponding author: Camila Aquino; Email: camila.aquino@ucalgary.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , Volume 53 , Issue 2 , March 2026 , pp. 246
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Wagle Shukla, A, Deeb, W, Patel, B, Ramirez-Zamora, A. Is deep brain stimulation therapy underutilized for movement disorders? Expert Rev Neurother. 2018;18:899–901. doi: 10.1080/14737175.2018.1538791.CrossRefGoogle ScholarPubMed
Sarno, M, Buré-Reyes, A, Harcourt, S, et al. Success of home-to-home tele-neuropsychology (TeleNP) in deep brain stimulation (DBS) candidacy assessments: COVID-19 and beyond. Parkinsonism Relat Disord. 2022;98:56–61. doi: 10.1016/j.parkreldis.2022.04.009.CrossRefGoogle ScholarPubMed
Zeng, Z, Lin, Z, Chen, Z, et al. Remote levodopa challenge test in Parkinson’s disease: feasibility, reliability, validity and economic value. Eur J Neurol. 2024;31:e16423. doi: 10.1111/ene.16423.CrossRefGoogle ScholarPubMed
Fung, WKW, Justich, MB, Hamani, M, et al. Remote deep brain stimulation programming in Canada. Mov Disord Clin Pract. 2024;11:586–589. doi: 10.1002/mdc3.13999.CrossRefGoogle ScholarPubMed
Neilson, LE, Wilhelm, J, McDonnell, MM, Mann, L, Kraakevik, JA. Extension of community healthcare outcomes in Parkinson disease (Parkinson ECHO): A feasibility study. Clin Park Relat Disord. 2022;7:100167. doi: 10.1016/j.prdoa.2022.100167.Google ScholarPubMed
Borovečki, F, Perković, R, Kovacs, N, LeWitt, PA, Bar, MR, Katzenschlager, R. Are Parkinson’s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged? J Neural Transm (Vienna). 2023;130:1405–1409. doi: 10.1007/s00702-023-02680-z.CrossRefGoogle ScholarPubMed